TrialCancer medicine2021

Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trial.

David E Spaner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.